Tania Buehler1, Lia Bally2, Ayse Sila Dokumaci1, Christoph Stettler2, and Chris Boesch1
1Depts. Radiology and Clinical Research, University of Bern, Bern, Switzerland, 2Division of Endocrinology, Diabetes and Clinical Nutrition, Inselspital Bern, Bern, Switzerland
Synopsis
In comparison to healthy subjects, there is scarce data on the influence
of different carbohydrate-types on the metabolism in exercising individuals
with type 1 diabetes mellitus (T1DM). Based on 13C-MRS, blood
sampling, stable isotopes, and indirect calorimetry the impact of glucose-fructose
and glucose-alone was investigated in T1DM subjects without prior insulin reduction.
Glucose-fructose ingestion showed a shift in fuel metabolism towards increased
fat oxidation and potential glycogen sparing effects. Despite the negative
reputation of fructose it seems to be a more efficient fuel in exercising
T1DM subjects, since blood glucose levels are not immediately elevated due to
its different metabolization.PURPOSE
Physical activity
provides many health benefits to individuals with type 1 diabetes mellitus
(T1DM), but poses high demands with regard to blood glucose control [1, 2, 3]. Adaptation of insulin therapy and/or ingestion of
carbohydrates (CHO) are generally recommended to avoid exercise-related
hypoglycemia. However, there is a paucity of data on the impact of different
CHO types on exercise-associated blood glucose and fuel metabolism in T1DM. The purpose of the present study was to evaluate
the metabolic effects of combined glucose-fructose and glucose-alone ingestion in exercising individuals with
T1DM without pre-exercise insulin reduction.
METHODS
For this prospective,
cross-over study evaluating metabolic response following two different ingestions
of carbohydrate solutions (GLU, GLU-FRU) during
a prolonged exercise 11
male complication-free individuals with T1DM (26±4y, BMI: 25.3±3.8 kg/m
2, mean HbA1c 7.0±0.6%, diabetes duration>5years) were recruited. A
screening visit (assessment of anthropometrics, basic metabolic rate, and body
composition) was performed prior to the trials, whereas for the exercise an
incremental cardiopulmonary exercise test and a familiarization to the planned
exercise intervention were carried out. All subjects followed a 2-day standardization protocol
prior to the
13C-MRS glycogen examinations in liver and the right
quadriceps muscle. Standardization involved a diet with a predefined daily
carbohydrate intake (50% of daily energy requirements according to a metabolic
assessment using indirect calorimetry, withdrawal from exercise, and avoidance
of alcohol and caffeine).
Patients injected their usual insulin dose and had a standardized breakfast
before 7 am on the four separated test days involving two baseline glycogen
measurements, an exercise intervention (following ingestion of either a GLU or
GLU-FRU mixture) with hepatic and myocellular glycogen measurements afterwards.
The isoenergetic exercise intervention consisted of a 90 min cycling session at
50% VO
2 max. Stable euglycemia was maintained using either oral
glucose (100g glucose/L, 0.5% U-
13C
6-glucose labelled) or
glucose-fructose (100g glucose/L and 100g fructose/L, 0.5% U-
13C
6-fructose
labelled) solution following a pre-specified algorithm. MR
localizer images and
1H decoupled natural abundance
13C
spectra (see Fig. 1) were recorded on a standard clinical 3.0 Tesla MR scanner
(TRIO, Siemens Erlangen, Germany) using a transmit-receive
1H/
13C
flexible surface coil (RAPID Biomedical GmbH, Rimpar, Germany). The metabolic
assessment included a dual stable isotope approach (intravenous
6,6-
2H
2-glucose, oral
13C-glucose/fructose)
and measurements of whole body substrate oxidation using indirect calorimetry.
RESULTS
Regarding the comparison between the two different
ingestion schemes (GLU vs. GLU-FRU), mean±SEM of the total amount of required CHO
immediately before and during exercise to maintain glycemia was comparable (34±4g vs. 31±3g; p=0.49). Mean±SEM levels of blood glucose (GLU: 7.7±0.3mM vs. GLU-FRU:
7.9±0.3mM; p=0.6) and insulin (GLU:
20.7±0.2mU/l vs. GLU-FRU: 20.5±0.2mU/l; p=1.00)
were comparable between both interventions. Lactate concentrations were
significantly higher during GLU-FRU (GLU: 2.1±0.2mM vs. GLU-FRU: 2.5±0.2mM, p=0.02). Counterregulatory hormones (adrenaline,
noradrenaline, growth hormones, cortisol, and glucagon) did not differ between
interventions. Rates of glucose appearance (Ra) and disappearance (Rd) were
comparable (Ra 7.7±0.4 mg/kg*min and 7.5±0.5 mg/kg*min, p=0.7; Rd 8.3±0.4 mg/kg*min and 8.4±0.2 mg/kg*min, p=0.9 for GLU and GLU-FRU). In GLU-FRU
the mean fructose ingestion rate was 2.1 mg/kg*min and the mean gluconeogenesis
from fructose was 1.3 mg/kg*min. With regard to substrate oxidation fat
oxidation was significantly higher (5.6±0.3mg/kg*min vs. 2.5±0.2mg/kg*min,
p<0.001) and CHO oxidation was significantly lower (16.9±1.0mg/kg*min vs.
23.9±0.9mg/kg*min, p<0.001) in GLU-FRU compared to GLU. Mean change in
hepatic glycogen content (see Fig. 2, 3) following GLU was -29%±8% compared to -19%±11% following GLU-FRU (p=0.76). Regarding myocellular glycogen
consumption, GLU lead to a mean change in glycogen content of -42%±5%, whereas mean change following
GLU-FRU was -42% ±4% (p=0.66). Combined tracer and indirect
calorimetry data however suggest peripheral glycogen sparing in GLU-FRU giving
the comparable rates of plasma glucose oxidation and significantly lower net
carbohydrate oxidation.
CONCLUSION
Mixed ingestion of a glucose-fructose
solution in exercising volunteers with T1DM without prior insulin adaption appears
to induce a shift towards increased fat oxidation and potential glycogen
sparing effects when compared to glucose alone.
Acknowledgements
Supported
by the Swiss National Science Foundation
(#320030-149321, #310030-149779) and the Ruth & Arthur Scherbarth StiftungReferences
[1] King,H. et. al. Diabetes Care 21:1414-1431;1998, [2] Randle,P.
et. al. Lancet 1:785-789;1963, [3] Tappy,L. et. al.
Physiol Rev 90:23-46;2010